Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
Bisel, Blaine E
Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation. [electronic resource] - Annals of the New York Academy of Sciences Feb 2007 - 58-63 p. digital
Publication Type: Journal Article
0077-8923
10.1196/annals.1379.020 doi
Adenylyl Cyclase Inhibitors
Adrenergic beta-Agonists--pharmacology
Alzheimer Disease--metabolism
Amyloid beta-Peptides--pharmacology
Animals
Colforsin--pharmacology
Enzyme Inhibitors
Excitatory Postsynaptic Potentials--drug effects
Hippocampus--drug effects
Isoproterenol--pharmacology
Long-Term Potentiation--physiology
Magnesium--physiology
Male
Peptide Fragments--pharmacology
Rats
Rats, Inbred F344
Synapses--drug effects
Synaptic Transmission--drug effects
Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation. [electronic resource] - Annals of the New York Academy of Sciences Feb 2007 - 58-63 p. digital
Publication Type: Journal Article
0077-8923
10.1196/annals.1379.020 doi
Adenylyl Cyclase Inhibitors
Adrenergic beta-Agonists--pharmacology
Alzheimer Disease--metabolism
Amyloid beta-Peptides--pharmacology
Animals
Colforsin--pharmacology
Enzyme Inhibitors
Excitatory Postsynaptic Potentials--drug effects
Hippocampus--drug effects
Isoproterenol--pharmacology
Long-Term Potentiation--physiology
Magnesium--physiology
Male
Peptide Fragments--pharmacology
Rats
Rats, Inbred F344
Synapses--drug effects
Synaptic Transmission--drug effects